Claraphi Advisory Network’s Ginkgo Bioworks DNA Stock Holding History

Claraphi Advisory Network’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$58.9K	Buy	872 +601	+222%	+$55.3K	0.02%	157
2022 Q3	$34K	Buy	+271	New	+$32.3K	0.02%	192
2022 Q1	–	Sell	-1,037	Closed	-$345K	–	296
2021 Q4	$345K	Buy	+1,037	New	+$493K	0.12%	191

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Claraphi Advisory Network's DNA Position: Q4 2022 in Review

Claraphi Advisory Network increased its Ginkgo Bioworks (DNA) stake by 222% in Q4 2022, buying an estimated $55.3K and bringing the position to 872 shares worth $58.9K. The position accounts for 0.02% of the portfolio, ranked #157.

Claraphi Advisory Network first reported a position in DNA in Q4 2021 and has held it in 3 quarters since. The position peaked at $345K in Q4 2021. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

Claraphi Advisory Network held 872 shares of Ginkgo Bioworks worth $58.9K as of Q4 2022.
Claraphi Advisory Network bought 601 Ginkgo Bioworks shares in Q4 2022, an estimated $55.3K.
Ginkgo Bioworks made up 0.02% of Claraphi Advisory Network's portfolio in Q4 2022, its #157 holding.
Claraphi Advisory Network first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 3 quarters since.
Claraphi Advisory Network's Ginkgo Bioworks position peaked at $345K in Q4 2021.
320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.